Vectormune® FP MG + AE product information

VACCINE PRESENTATION

  • Freeze-dried

ROUTE OFADMINISTRATION

  • Wing-web

AGE OF ADMINISTRATION

  • 8-week-old chickens

APPROVED SPECIES

  • Chickens
Vectormune FP MG + AE packshot

VACCINE TYPE

  • Live FP-vectored MG vaccine in combination with classic live AE virus

VACCINE CONSTRUCT

  • Vector: Live Fowl Pox
  • Contains insert of the field R MG strain and insert of the S6 MG strain
  • Live Avian Encephalo myelitis virus

DISEASE PROTECTION

  • Mycoplasma gallisepticum
  • Fowl Pox
  • Avian Encephalomyelitis

VECTORMUNE® FP MG & AE is a genetically engineered live virus vaccine for the vaccination of chickens as an aid in the prevention of fowl pox and Mycoplasma gallisepticum. The vaccine also contains a conventional live v

INDICATIONSirus for vaccination as an aid in the prevention of avian encephalomyelitis. The fowl pox vaccine has been genetically engineered to contain and express key protective Mycoplasma gallisepticum bacterial antigens.

Administer by wing web to healthy, susceptible chickens at least eight weeks of age but at least four weeks prior to the start of egg production. Chickens receiving this vaccine must not have been previously vaccinated with a fowl pox vaccine.

DOSAGE AND ADMINISTRATION

Remove seal and stopper from vaccine vial and diluent vial. Pour entire contents of diluent vial into vaccine vial, insert stopper, and shake well. The vaccine is ready for use and should be used within one hour. Hold each individual bird and spread the wing with the underside facing up. Dip the two-pronged wing web applicator into the vaccine so that the grooves fill with liquid and deliver 0.01 mL per bird. Insert the double-pronged applicator into the web portion of the wing avoiding blood vessels, muscle, and bone. Seven to 10 days after vaccination, observe several chickens for evidence of “takes” that include swelling and/or scab formation at the site of injection.

For veterinary use only